Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 126.67 USD 1.25% Market Closed
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Income Statement

Earnings Waterfall
Jazz Pharmaceuticals PLC

Revenue
4B USD
Cost of Revenue
-424.2m USD
Gross Profit
3.6B USD
Operating Expenses
-2.9B USD
Operating Income
703.7m USD
Other Expenses
-240.5m USD
Net Income
463.2m USD

Income Statement
Jazz Pharmaceuticals PLC

Rotate your device to view
Income Statement
Currency: USD
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
1 081
N/A
1 173
+9%
1 235
+5%
1 278
+3%
1 312
+3%
1 325
+1%
1 352
+2%
1 399
+4%
1 432
+2%
1 488
+4%
1 528
+3%
1 541
+1%
1 579
+2%
1 619
+3%
1 687
+4%
1 793
+6%
1 851
+3%
1 891
+2%
1 955
+3%
1 988
+2%
2 057
+3%
2 162
+5%
2 188
+1%
2 217
+1%
2 280
+3%
2 364
+4%
2 436
+3%
2 626
+8%
2 863
+9%
3 094
+8%
3 300
+7%
3 481
+5%
3 584
+3%
3 659
+2%
3 739
+2%
3 763
+1%
3 794
+1%
3 834
+1%
3 843
+0%
3 910
+2%
3 993
+2%
Gross Profit
Cost of Revenue
(114)
(117)
(115)
(106)
(107)
(103)
(98)
(100)
(96)
(105)
(107)
(112)
(119)
(110)
(119)
(125)
(120)
(122)
(121)
(114)
(119)
(128)
(123)
(123)
(134)
(149)
(161)
(252)
(355)
(441)
(516)
(521)
(509)
(541)
(554)
(527)
(496)
(436)
(402)
(415)
(424)
Gross Profit
966
N/A
1 056
+9%
1 120
+6%
1 172
+5%
1 205
+3%
1 222
+1%
1 254
+3%
1 299
+4%
1 337
+3%
1 383
+3%
1 421
+3%
1 430
+1%
1 460
+2%
1 509
+3%
1 568
+4%
1 668
+6%
1 731
+4%
1 769
+2%
1 833
+4%
1 874
+2%
1 938
+3%
2 034
+5%
2 065
+2%
2 093
+1%
2 146
+3%
2 215
+3%
2 276
+3%
2 374
+4%
2 508
+6%
2 654
+6%
2 785
+5%
2 961
+6%
3 075
+4%
3 119
+1%
3 185
+2%
3 236
+2%
3 299
+2%
3 399
+3%
3 441
+1%
3 495
+2%
3 568
+2%
Operating Income
Operating Expenses
(773)
(819)
(699)
(705)
(664)
(681)
(758)
(771)
(771)
(789)
(815)
(827)
(906)
(980)
(1 088)
(1 157)
(1 117)
(1 112)
(1 174)
(1 162)
(1 281)
(1 502)
(1 720)
(1 754)
(1 744)
(1 701)
(1 546)
(1 835)
(2 135)
(2 254)
(2 689)
(2 524)
(2 469)
(3 010)
(3 212)
(3 191)
(3 106)
(2 720)
(2 867)
(2 879)
(2 865)
Selling, General & Administrative
(381)
(404)
(410)
(416)
(427)
(448)
(464)
(480)
(500)
(501)
(517)
(527)
(527)
(544)
(607)
(633)
(665)
(684)
(644)
(662)
(685)
(737)
(777)
(793)
(821)
(854)
(906)
(1 067)
(1 222)
(1 223)
(1 278)
(1 252)
(1 207)
(1 376)
(1 325)
(1 340)
(1 330)
(1 262)
(1 370)
(1 367)
(1 385)
Research & Development
(276)
(288)
(170)
(178)
(131)
(135)
(148)
(159)
(171)
(186)
(191)
(194)
(254)
(283)
(301)
(315)
(244)
(227)
(280)
(289)
(369)
(410)
(582)
(599)
(556)
(587)
(375)
(426)
(478)
(506)
(559)
(635)
(643)
(1 035)
(1 095)
(1 096)
(1 182)
(850)
(883)
(895)
(860)
Depreciation & Amortization
(115)
(127)
(120)
(111)
(107)
(98)
(96)
(99)
(100)
(102)
(105)
(105)
(125)
(152)
(179)
(208)
(208)
(202)
(205)
(212)
(228)
(355)
(361)
(362)
(366)
(260)
(265)
(343)
(436)
(526)
(630)
(638)
(619)
(599)
(577)
(581)
(594)
(608)
(614)
(617)
(620)
Other Operating Expenses
0
0
0
0
0
0
(50)
(33)
0
0
0
0
0
0
0
0
0
0
(44)
0
0
0
0
0
0
0
0
0
0
0
(222)
0
0
0
(215)
(175)
0
0
0
0
0
Operating Income
193
N/A
237
+22%
421
+78%
467
+11%
541
+16%
541
+0%
496
-8%
528
+6%
566
+7%
593
+5%
606
+2%
602
-1%
555
-8%
529
-5%
481
-9%
512
+6%
614
+20%
658
+7%
659
+0%
712
+8%
656
-8%
532
-19%
345
-35%
339
-2%
402
+19%
514
+28%
730
+42%
539
-26%
373
-31%
399
+7%
96
-76%
437
+356%
606
+39%
109
-82%
(27)
N/A
45
N/A
193
+327%
678
+252%
574
-15%
616
+7%
704
+14%
Pre-Tax Income
Interest Income Expense
(37)
(44)
(48)
(54)
(60)
(56)
(54)
(49)
(55)
(59)
(67)
(78)
(81)
(89)
(91)
(90)
(88)
(86)
(82)
(79)
(78)
(78)
(79)
(81)
(90)
(98)
(105)
(149)
(218)
(283)
(338)
(336)
(325)
(307)
(297)
(308)
(296)
(281)
(278)
(263)
(250)
Non-Reccuring Items
(33)
(41)
(42)
(26)
(26)
(50)
0
0
(33)
(2)
0
0
(2)
0
0
(44)
(44)
(44)
0
0
0
0
(136)
(141)
(141)
(141)
(5)
(78)
(79)
(229)
0
(186)
(359)
(174)
0
0
0
(100)
(55)
(55)
(55)
Pre-Tax Income
124
N/A
152
+23%
331
+118%
387
+17%
455
+18%
436
-4%
441
+1%
479
+9%
478
0%
532
+11%
540
+1%
524
-3%
473
-10%
440
-7%
390
-11%
377
-3%
481
+28%
527
+10%
577
+9%
633
+10%
578
-9%
454
-21%
130
-71%
117
-10%
171
+46%
275
+61%
620
+125%
313
-50%
77
-75%
(113)
N/A
(242)
-115%
(85)
+65%
(78)
+9%
(373)
-380%
(324)
+13%
(263)
+19%
(104)
+61%
298
N/A
241
-19%
297
+23%
399
+34%
Net Income
Tax Provision
(93)
(94)
(109)
(121)
(126)
(106)
(107)
(118)
(115)
(135)
(125)
(118)
(93)
(107)
(97)
(98)
(116)
(80)
(90)
25
34
73
154
20
12
(34)
(103)
(277)
(239)
(216)
(199)
46
71
159
174
183
187
120
93
99
67
Income from Continuing Operations
31
57
222
266
328
330
335
361
363
397
415
406
380
333
292
279
365
447
487
658
612
528
283
137
183
242
517
36
(163)
(329)
(441)
(39)
(7)
(214)
(150)
(81)
83
418
334
397
465
Income to Minority Interest
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Equity Earnings Affiliates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(2)
(3)
(4)
(3)
(4)
(4)
(3)
1
4
2
(1)
(9)
(13)
(12)
(10)
(7)
(6)
(3)
(3)
(3)
(2)
(2)
Net Income (Common)
32
N/A
58
+82%
222
+280%
266
+20%
328
+23%
330
+0%
335
+2%
361
+8%
363
+0%
397
+9%
415
+5%
406
-2%
380
-6%
488
+28%
447
-8%
434
-3%
520
+20%
447
-14%
486
+9%
656
+35%
609
-7%
523
-14%
280
-46%
133
-52%
179
+34%
239
+33%
518
+117%
40
-92%
(161)
N/A
(330)
-105%
(450)
-36%
(52)
+88%
(19)
+64%
(224)
-1 098%
(156)
+30%
(87)
+45%
80
N/A
415
+419%
331
-20%
395
+19%
463
+17%
EPS (Diluted)
0.51
N/A
0.93
+82%
3.52
+278%
4.21
+20%
5.19
+23%
5.23
+1%
5.34
+2%
5.82
+9%
5.87
+1%
6.41
+9%
6.78
+6%
6.6
-3%
6.18
-6%
7.95
+29%
7.3
-8%
7.06
-3%
8.39
+19%
7.3
-13%
8.37
+15%
11.42
+36%
10.6
-7%
9.09
-14%
5
-45%
2.38
-52%
3.17
+33%
4.22
+33%
8.87
+110%
0.67
-92%
-2.62
N/A
-5.52
-111%
-7.15
-30%
-0.81
+89%
-0.3
+63%
-3.58
-1 093%
-2.11
+41%
-1.17
+45%
1.12
N/A
5.75
+413%
5.28
-8%
5.67
+7%
7.33
+29%

See Also

Discover More